World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 18 April 2017
Main ID:  ChiCTR-TRC-13003639
Date of registration: 2013-09-07
Prospective Registration: No
Primary sponsor: Peking University Third Hospital
Public title: The application of Analgesia Nociception Index guided Remifentanil administration during general anesthesia for Spinal Surgery
Scientific title: The application of Analgesia Nociception Index guided Remifentanil administration during general anesthesia for Spinal Surgery
Date of first enrolment: 2012-09-13
Target sample size: ANI group:30;control group:30;
Recruitment status: Completed
URL:  http://www.chictr.org.cn/showproj.aspx?proj=5921
Study type:  Interventional study
Study design:  Randomized parallel controlled trial  
Phase:  Other
Countries of recruitment
China
Contacts
Name: Duan Yi   
Address:  49 North Garden Road, Haidian District, Beijing, China 100191
Telephone: +86 18810533317
Email: yiduan1987@163.com
Affiliation:  Department of Anesthesia, Third Hospital, Peking University
Name: Liping Zhang   
Address:  49 North Garden Road, Haidian District, Beijing, China 100191
Telephone: +86 13911113805
Email: lipingzhang01@aliyun.com
Affiliation:  Department of Anesthesia, Third Hospital, Peking University
Key inclusion & exclusion criteria
Inclusion criteria: ASA status I-II, aged 18-70 years, BMI 17-33kg.m-2, scheduled for elective posterior lumbar decompression and internal fixation for treatment of lumbar canal stenosis and/or lumbar disc herniation.
Exclusion criteria: pregnancy, non sinus rhythms, ANS altering diseases or medications, allergy to drugs used in this study ,baseline hemodynamic index that would be considered as abnormal(such as SBP>160mmHg or SBP<90mmHg,HR>90min-1or HR<45 min-1).

Age minimum: 18
Age maximum: 70
Gender: Both
Health Condition(s) or Problem(s) studied
Lumbar spinal stenosis and/or lumbar intervertebral disc herniation
Intervention(s)
ANI group:ANI guide the administration of remifentanil;control group:remifentanil was adapted by Anaesthesiologist corresponding to clinical experiences ;
Primary Outcome(s)
total number of unwanted events;the consumption of anesthetics;
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
self-finacing
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history